GENAPAX Drug Patent Profile
✉ Email this page to a colleague
When do Genapax patents expire, and what generic alternatives are available?
Genapax is a drug marketed by Key Pharms and is included in one NDA.
The generic ingredient in GENAPAX is gentian violet. Additional details are available on the gentian violet profile page.
Summary for GENAPAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 179 |
Patent Applications: | 2,007 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GENAPAX at DailyMed |
US Patents and Regulatory Information for GENAPAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Key Pharms | GENAPAX | gentian violet | TAMPON;VAGINAL | 085017-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |